These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11256478)

  • 21. Synergistic effect of 1α,25-dihydroxyvitamin D
    Li J; Padwa BL; Zhou S; Mullokandova J; LeBoff MS; Glowacki J
    J Steroid Biochem Mol Biol; 2018 Mar; 177():103-108. PubMed ID: 28765038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3.
    Van Auken M; Buckley D; Ray R; Holick MF; Baran DT
    J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 1,25(OH)2D3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells.
    Mahonen A; Pirskanen A; Keinänen R; Mäenpää PH
    Biochim Biophys Acta; 1990 Jan; 1048(1):30-7. PubMed ID: 2153413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells.
    Wang DS; Miura M; Demura H; Sato K
    Endocrinology; 1997 Jul; 138(7):2953-62. PubMed ID: 9202240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
    Chen TL; Hauschka PV; Feldman D
    Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of transforming growth factor beta (TGF beta) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells.
    Ingram RT; Bonde SK; Riggs BL; Fitzpatrick LA
    Differentiation; 1994 Jan; 55(2):153-63. PubMed ID: 8143932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,25-Dihydroxyvitamin D3, recombinant human transforming growth factor-beta 1, and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells.
    Nozaki K; Kadosawa T; Nishimura R; Mochizuki M; Takahashi K; Sasaki N
    J Vet Med Sci; 1999 Jun; 61(6):649-56. PubMed ID: 10423687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
    Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
    Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
    Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation, identification and biological activity of 24R,25-dihydroxy-3-epi-vitamin D3: a novel metabolite of 24R,25-dihydroxyvitamin D3 produced in rat osteosarcoma cells (UMR 106).
    Kamao M; Tatematsu S; Reddy GS; Hatakeyama S; Sugiura M; Ohashi N; Kubodera N; Okano T
    J Nutr Sci Vitaminol (Tokyo); 2001 Apr; 47(2):108-15. PubMed ID: 11508700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
    Sterck JG; Klein-Nulend J; Burger EH; Lips P
    J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human osteoblasts exhibit sexual dimorphism in their response to estrogen on microstructured titanium surfaces.
    Berger MB; Cohen DJ; Olivares-Navarrete R; Williams JK; Cochran DL; Boyan BD; Schwartz Z
    Biol Sex Differ; 2018 Jul; 9(1):30. PubMed ID: 29970177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx.
    Khoury R; Ridall AL; Norman AW; Farach-Carson MC
    Endocrinology; 1994 Dec; 135(6):2446-53. PubMed ID: 7988430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
    Inaba M; Terada M; Koyama H; Yoshida O; Ishimura E; Kawagishi T; Okuno Y; Nishizawa Y; Otani S; Morii H
    J Bone Miner Res; 1995 Jul; 10(7):1050-6. PubMed ID: 7484280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
    Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
    J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dehydroepiandrosterone (DHEA) and DHEA-S interact with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) to stimulate human osteoblastic cell differentiation.
    Scheven BA; Milne JS
    Life Sci; 1998; 62(1):59-68. PubMed ID: 9444968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependent expression of osteoblastic phenotypic markers in normal human osteoblasts cultured long-term in the presence of dexamethasone.
    Sutherland MS; Rao LG; Muzaffar SA; Wylie JN; Wong MM; McBroom RJ; Murray TM
    Osteoporos Int; 1995; 5(5):335-43. PubMed ID: 8800783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.